x

This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 




Myriad sues Ambry over cancer gene screening tests

10-07-2013

Biotech company Myriad Genetics has filed a patent infringement case against Ambry Genetic Corp for allegedly infringing 10 patents related to genetic diagnostic testing.


Myriad, Ambry, patent infringement, gene patents, diagnostic tests

More on this story

Myriad patent suit enters antitrust territory
08-08-2013

WIPR

Payment types accepted